Filing metadata

Accession number
0001209191-21-000442
Form type
Form 3
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Jan 04, 2021
Reporting period
Jan 01, 2021
Description
Initial ownership

Explore SEC Filings Hub